141 related articles for article (PubMed ID: 11151773)
1. [Atrial defibrillators].
Heisel A; Jung J; Buob A; Siaplaouras S
Z Kardiol; 2000; 89 Suppl 10():35-41; discussion 41-2. PubMed ID: 11151773
[TBL] [Abstract][Full Text] [Related]
2. The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system?
Heisel A; Jung J
Am J Cardiol; 1999 Mar; 83(5B):218D-226D. PubMed ID: 10089869
[TBL] [Abstract][Full Text] [Related]
3. [Atrial defibrillator].
Jung W; Lüderitz B
Herz; 1998 Jun; 23(4):251-9. PubMed ID: 9690112
[TBL] [Abstract][Full Text] [Related]
4. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
5. Internal defibrillation: where we have been and where we should be going?
Lévy S
J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():61-6. PubMed ID: 16133857
[TBL] [Abstract][Full Text] [Related]
6. Atrial defibrillation: can modifications in current implantable cardioverter-defibrillators achieve this?
Heisel A; Jung J; Fries R; Schieffer H; Ozbek C
Am J Cardiol; 1996 Sep; 78(5A):119-27. PubMed ID: 8820848
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with implantable atrial and combined atrioventricular defibrillators.
Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Schimpf R; Vahlhaus C; Welz A; Lüderitz B
J Interv Card Electrophysiol; 2000 Jan; 4 Suppl 1():185-95. PubMed ID: 10590507
[TBL] [Abstract][Full Text] [Related]
8. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
Heisel A; Jung J; Fries R; Stopp M; Sen S; Schieffer H; Ozbek C
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):65-71. PubMed ID: 9121973
[TBL] [Abstract][Full Text] [Related]
9. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system.
Schoels W; Swerdlow CD; Jung W; Stein KM; Seidl K; Haffajee CJ;
J Cardiovasc Electrophysiol; 2001 May; 12(5):521-8. PubMed ID: 11386511
[TBL] [Abstract][Full Text] [Related]
10. Specific considerations with the automatic implantable atrial defibrillator.
Jung W; Wolpert C; Esmailzadeh B; Spehl S; Herwig S; Schumacher B; Lewalter T; Omran H; Kirchhoff PG; Lüderitz B
J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S193-201. PubMed ID: 9727697
[TBL] [Abstract][Full Text] [Related]
11. Transvenous atrial cardioversion threshold in patients with implantable cardioverter defibrillator: influence of active pectoral can.
Heisel A; Jung J; Nikoloudakis N; Fries R; Schäfers HJ; Schieffer H
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):253-7. PubMed ID: 9990641
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias.
Boriani G; Wollmann C; Biffi M; Kühl M; Schuchert A; Sperzel J; Stiller S; Gasparini G; Böcker D
Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):461-5. PubMed ID: 12687868
[TBL] [Abstract][Full Text] [Related]
13. The future role of defibrillators in the management of atrial fibrillation.
Ayers GM; Griffin JC
Curr Opin Cardiol; 1997 Jan; 12(1):12-7. PubMed ID: 9132075
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
[TBL] [Abstract][Full Text] [Related]
15. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
16. Intra-atrial defibrillation in humans.
Lüderitz B; Jung W
Thorac Cardiovasc Surg; 1999 Aug; 47 Suppl 3():342-6. PubMed ID: 10520765
[TBL] [Abstract][Full Text] [Related]
17. Low-energy transvenous cardioversion of atrial fibrillation using a single atrial lead system.
Heisel A; Jung J; Neuzner J; Michel U; Pitschner H
J Cardiovasc Electrophysiol; 1997 Jun; 8(6):607-14. PubMed ID: 9209961
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
Gold MR; Leman RB; Euler DE
Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
[TBL] [Abstract][Full Text] [Related]
19. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
[TBL] [Abstract][Full Text] [Related]
20. The role of implantable devices to treat atrial fibrillation.
Santini L; Santini M
Future Cardiol; 2015; 11(6):689-95. PubMed ID: 26609562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
